SCHEMBL4026362

SCHEMBL4026362

CC1NC(=O)OC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10110368 1.00
SCHEMBL14231549 1.00
SCHEMBL22313102 1.00
SCHEMBL11686574 0.74
SCHEMBL17578002 0.74
SCHEMBL13905572 0.74
SCHEMBL14561267 0.72
SCHEMBL19000173 0.72
SCHEMBL16889289 0.72
SCHEMBL4458205 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0471591-B1 Process for absorption of sulfur compounds from fluids using heterocyclic compounds having at least one ring nitrogen atom DOW CHEMICAL CO (US) 1995-05-10 EP claimed
US-5342593-A Contacting with a hydantoin, triazinone, 2,4-pyrimidinedione or oxazolidone; can be regenerated THE DOW CHEMICAL COMPANY (US) 1994-08-30 US claimed
EP-0552360-A1 A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE THE DOW CHEMICAL COMPANY (US) 1993-07-28 EP claimed
WO-1993003825-A1 A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE THE DOW CHEMICAL COMPANY (US) 1993-03-04 WO claimed
US-5167941-A Sulfur dioxide; cationic polyelectrolyte stabilizers THE DOW CHEMICAL COMPANY (US) 1992-12-01 US claimed
EP-0471591-A2 Process for absorption of sulfur compounds from fluids using heterocyclic compounds having at least one ring nitrogen atom THE DOW CHEMICAL COMPANY (US) 1992-02-19 EP claimed
US-20230183214-A1 IL4I1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC 2023-06-15 US disclosed
WO-2021226003-A1 IL4I1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME CORP. (US) 2021-11-11 WO disclosed
US-9839641-B2 Compounds and methods for treating bacterial infections ENTASIS THERAPEUTICS LIMITED (GB) 2017-12-12 US disclosed
US-20170128458-A1 COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS ENTASIS THERAPEUTICS INC. 2017-05-11 US disclosed
US-9540394-B2 Compounds and methods for treating bacterial infections ENTASIS THERAPEUTICS LIMITED (GB) 2017-01-10 US disclosed
US-20160193310-A1 RM2 ANTIGENS AND USE THEREOF ACADEMIA SINICA 2016-07-07 US disclosed
US-20160175421-A1 GLYCAN CONJUGATES AND USE THEREOF WONG CHI-HUEY (US) 2016-06-23 US disclosed
EP-0244810-A1 Process for producing 2-oxazolidinones MITSUI TOATSU CHEMICALS, Inc. (JP) 1987-11-11 EP disclosed
US-4058462-A System for sustained release of phenolic material from porous granules of insoluble polymeric phenolic complexes GAF CORPORATION (US) 1977-11-15 US disclosed
US-4000293-A METHOD OF INHIBITING BACTERIAL GROWTH WITH CERTAIN SELECTED 3-CHLORO-2-OXAZOLIDINONES INTERX RESEARCH CORPORATION (US) 1976-12-28 US disclosed
US-3985540-A Metal complexes of hydroxyquinoline and polymeric porous granules GAF CORPORATION (US) 1976-10-12 US disclosed
US-3970606-A N-vinyl lactam interpolymers useful as thickening agents GAF CORPORATION (US) 1976-07-20 US disclosed
US-3954682-A GRANULES OR BEADS GAF CORPORATION (US) 1976-05-04 US disclosed
US-3931213-A BACTERICIDE INTERX RESEARCH CORPORATION (US) 1976-01-06 US disclosed